Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

FDA confirms Class I recall for vascular device used by cardiologists and surgeons
The issue at the heart of this recall has been linked to three patient deaths.
Nationwide private-equity backed hospital chain announces shift to nonprofit business model
Quorum Health said the move will allow it to save money through tax exemptions and provide its 11 hospitals with access to the 340B Drug Pricing Program. The health system is majority-owned by Goldentree Asset Management.
BATMAN to the rescue: TMVR technique helps cardiologists reduce risk of LVOT obstruction
LVOT obstruction is a serious complication of TMVR. BATMAN may help protect patients from LVOT obstruction without leading to any additional risks.
How TAVR valve implant depth impacts clinical outcomes
TAVR procedures with a higher implant depth are associated with certain clinical benefits after one year, according to a new study of data from more than 600 patients.
Long COVID resurfaces in the national dialogue after long absence from the headlines
In early 2025 public health researchers at City University of New York projected Long COVID would cost the U.S. $6.6 billion over three years. This week two members of that research team amplified their findings and updated their projections.

FDA announces new recall of Medtronic surgical devices over safety concerns

The agency warned that any unused devices should be removed from the market and returned to the manufacturer.

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.

betting big on AI artificial intelligence in healthcare

Healthcare AI newswatch: Great expectations for GenAI, disaster-ready AI, Dr. Oz on payer AI, more

Investors are betting on generative AI to solve costly provider workflow inefficiencies. So are provider executives.

wearable health AI artificial intelligence

When health accessories grow up, they want to be wearable AI

Wearable health gadgets equipped with AI present myriad opportunities and challenges to healthcare consumers and the healthcare professionals who diagnose, treat and track them.

Timing is everything: Delaying noncardiac surgery after a heart procedure reduces risks

When patients require subsequent noncardiac surgery after a major heart operation, waiting at least 100 days is one way to limit the risk of an adverse event. Read the full analysis in JACC: Advances.

business marketing meal lunch food group project team building

Direct marketing to cardiologists increases uptake of some, but not all, heart failure drugs

Researchers tracked three years of CMS data to explore how meal-based marketing may influence the habits of general and advanced heart failure cardiologists.

Bard Peripheral Vascular Rotarex Atherectomy System recall

Safety update: FDA announces Class I recall due to atherectomy devices breaking during use

The FDA shared a warning about these safety issues in February, but said it was still reviewing the evidence. The agency is now saying the devices “may cause serious injury or death” if used without following the updated instructions for use.

Healthcare AI newswatch: California AI hoping, the jagged AI frontier, agents bumping off bots, more

California has moved assertively to legislate guardrails around AI in healthcare. Will other states follow?

Care Delivery

FDA confirms Class I recall for vascular device used by cardiologists and surgeons

Nationwide private-equity backed hospital chain announces shift to nonprofit business model

BATMAN to the rescue: TMVR technique helps cardiologists reduce risk of LVOT obstruction

How TAVR valve implant depth impacts clinical outcomes

Long COVID resurfaces in the national dialogue after long absence from the headlines